Obesity
Conditions
Brief summary
Background: The Mediterranean Diet (MD) is considered an healthy diet useful in the prevention of cardiovascular disease (CVD). High quality extra virgin olive oil (HQ-EVOO, \[1\]), an essential component of this diet, exerts a protective effect against CVD. Moreover, the gut microbiota (GM) has recently been recognized as a key factor in driving metabolic activities and involved in the stimulation of host immunity \[2\]. In particular, Lactic Acid Bacteria (LAB) and their probio-active cellular substances produce beneficial effects in the gastrointestinal tract, thus representing important assets in pathological conditions such as obesity and CVD \[3,4\]. Objective: The purpose of this study is to demonstrate that 3 months of treatment (MD with 40g/die HQ-EVOO) in 36 subjects (cases: overweight/obese vs controls: normal weight) may change their GM and inflammatory panel.
Interventions
Cases and controls were given 40 g/die high quality extra virgin olive oil
Sponsors
Study design
Eligibility
Inclusion criteria
* normal weight subjects (M and F) with Body Mass Index (BMI) between 18.5 and 24.9 Kg/m2 following MD; * overweight/obese subjects with a BMI ≥ 25 Kg/m2, not necessarily following MD.
Exclusion criteria
* eating disorders; * recent or ongoing antibiotic therapy.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| anti-inflammatory cytokines | Time 0 (T0) |
| changes in anti-inflammatory cytokines | after 3 months from T0 (T1) |